Press Release
SHARE:

FOR IMMEDIATE RELEASE

New Jersey Researcher Honored by AAN for Work in Restoring Movement after Stroke

Anna M. Barrett, MD, Receives Norman Geschwind Prize

ST. PAUL, Minn – The American Academy of Neurology (AAN) is awarding the 2007 Norman Geschwind Prize Award in Behavioral Neurology to Anna M. Barrett, MD, with the Kessler Medical Rehabilitation Research and Education Corporation (KMRREC) in West Orange, NJ, for her research in behavioral neurology. Barrett will receive the award during the American Academy of Neurology’s 59th Annual Meeting in Boston, held April 28 – May 5, 2007. The Norman Geschwind Prize is awarded to an individual for outstanding research in the field of behavioral neurology. Applicants should have a strong desire to expand the field of behavioral neurology through research. Barrett’s research focused on improving people’s ability to guide movements and spatial cognition after stroke. “Thousands of people in the United States have strokes affecting their ability to guide movement and attention. My research offers hope that we can design and implement scientific treatments to restore natural motor balance and abilities in stroke victims,” said Barrett, Director of Stroke Research at KMRREC (www.kmrrec.org/stroke). The award is sponsored by the AAN and the Behavioral Neurology Section and endowed through Dr. Norman Geschwind's family, friends, and colleagues; Pfizer Inc; and the Society for Behavioral and Cognitive Neurology. The 59th Annual Meeting takes place in Boston’s Hynes Convention Center. It is the world’s largest annual gathering of neurologists. For more information about the American Academy of Neurology, visit www.aan.com. –end–

The American Academy of Neurology, an association of more than 20,000 neurologists and neuroscience professionals, is dedicated to improving patient care through education and research. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as Alzheimer’s disease, epilepsy, multiple sclerosis, Parkinson’s disease, and stroke.


Log On

MEMBER LOG IN

Forgot password?

Press Release Search